Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricHLNHaleon PLCZTSZoetisTEVATeva Pharmaceutical Industries Ltd
Snapshot
Price$9.89$75.62$37.18
Market cap$40.75B$33.26B$32.95B
Valuation
P/E19x12.3x25.8x
Forward P/E16.2x11.4x—
Growth
Revenue growth-1.8%2.4%4.4%
EPS growth17.6%8.4%—
Profitability
Net margin15.1%27.8%9.0%
ROE10.3%62.4%20.7%
Balance sheet & cash
Debt / equity0.52x2.72x2.12x
Free cash flow yield0.5%7.5%-10.5%
Dividend yield1.9%1.6%—
Verdict
Investment ratingNeutral· 48Favorable· 63Weak· 33

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearHLNtoday $10ZTStoday $76TEVAtoday $37
2027$8.72 – $12.79+29% CAGR$61.47 – $90.16+19% CAGR$29.11 – $42.70+15% CAGR
2028$10.25 – $15.04+23% CAGR$66.63 – $97.73+14% CAGR$30.40 – $44.58+10% CAGR
2029$12.05 – $17.68+21% CAGR$72.22 – $105.92+12% CAGR$31.74 – $46.55+8% CAGR
2030$14.17 – $20.79+20% CAGR$78.28 – $114.81+11% CAGR$33.14 – $48.60+7% CAGR
2031$16.66 – $24.44+20% CAGR$84.85 – $124.44+10% CAGR$34.60 – $50.75+6% CAGR
5-yr CAGR11.0% – 19.8%2.3% – 10.5%-1.4% – 6.4%